Meanwhile, previous study has demonstrated that the THF transporter of SLC25A32 is highly expressed in varying tumors, and obviously facilitated tumor cell growth to reduce patients' survival, whereas downregulation of SLC25A32 inhibits tumor cell propagation [27]. Here, SLC25A32 is linked to neoplasm.